CEOs think Trump’s tariff plan is a ‘huge mistake,’ says Altimeter’s Brad Gerstner

CEOs think Trump’s tariff plan is a ‘huge mistake,’ says Altimeter’s Brad Gerstner


Key Points

  • The leaders of corporate America think the tariff policies announced by President Donald Trump on Wednesday went too far and will hurt the U.S. economy, according to Altimeter Capital CEO Brad Gerstner.
  • “I talked to probably 10 CEOs who are all in the Business Roundtable — these are CEOs of the largest companies in America — overnight, and [they all] think this is a huge mistake,” said Gerstner.
  • Gerstner did not specify who exactly he spoke to, but the members of the Business Roundtable include the CEOs of the biggest companies from multiple industries, including firms such as Apple, Bank of America, Boeing and FedEx.



Source

Sam Altman touts ChatGPT’s reaccelerating growth to employees as OpenAI closes in on 0 billion funding
World

Sam Altman touts ChatGPT’s reaccelerating growth to employees as OpenAI closes in on $100 billion funding

As OpenAI faces intensifying pressure from rival Anthropic’s improved coding tools, CEO Sam Altman is telling employees and investors that his company is seeing its share of momentum. Altman told OpenAI employees on Friday that ChatGPT, the company’s popular artificial intelligence chatbot, is “back to exceeding 10% monthly growth,” according to an internal Slack message […]

Read More
Databricks completes  billion funding round at 4 billion valuation
World

Databricks completes $5 billion funding round at $134 billion valuation

Ali Ghodsi, co-founder and CEO of Databricks. Databricks Databricks said Monday it has raised $5 billion in funding and $2 billion in new debt capacity at a $134 billion valuation. The privately held data analytics software company also said that its annualized revenue exceeded $5.4 billion for the January quarter, up 65% year over year, […]

Read More
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections
World

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. Tom Little | Reuters Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity pill and injections in […]

Read More